astrazeneca cspc - Search News

News

CSPC, AstraZeneca and AI

AstraZeneca and CSPC Pharmaceuticals enter AI-driven partnership worth $5.3bn

AstraZeneca (AZ) and CSPC Pharmaceuticals Group have entered into a partnership worth up to $5.3bn to develop therapies for chronic conditions.

The Wall Street Journal on MSN · 3d

AstraZeneca Enters Deal With CSPC Pharma Valued at Up to $5.33 Billion

The deal with China’s CSPC Pharmaceuticals, focused on AI-driven research, aims to advance the discovery and development of new drug candidates.

BioSpace · 3d

AstraZeneca Makes $5.3B AI Bet With China’s CSPC for Chronic Disease Pills

Friday’s deal with fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in China.

Fierce Biotech3d

AstraZeneca pens $5.3B pact to use CSPC's AI platform to develop oral drugs for chronic diseases

CSPC will use its artificial-intelligence-driven, dual-engine efficient drug discovery platform to analyze the binding ...

MedCity News2d

AstraZeneca Turns to CSPC Pharma Again, Putting Up $110M to Start Multi-Drug R&D Pact

AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

CSPC, AstraZeneca and AI

Trending now